Exosomes for repair, regeneration and rejuvenation

Expert Opinion on Biological Therapy

Volumn 16, Issue 4, 2016, Pages 489-506

  Basu, Joydeep ^a   Ludlow, John W ^a  

^a RegenMedTX LLC   (United States)

Author keywords

Cell therapy; Exosome; Extra cellular vesicle; Manufacturing; Micro vesicle; Morphogen; Organogenesis; Progenitor cell; Quality control; Regenerative medicine; Regulatory; Stem cell; Tissue engineering

Indexed keywords

ARBUTIN; AVOBENZONE; COSMECEUTICAL; GRANULOCYTE COLONY STIMULATING FACTOR; VACCINE;

BIOLOGICAL ACTIVITY; CATALYSIS; CELL ENCAPSULATION; CELL POPULATION; CELL THERAPY; CHRONIC DISEASE; DISEASES; EXOSOME; HUMAN; INJURY; MEMBRANE MICROPARTICLE; NERVE DEGENERATION; NONHUMAN; NUCLEIC ACID TRANSPORT; PRODUCT DEVELOPMENT; PROTEIN TRANSPORT; REGENERATION; REGENERATIVE MEDICINE; REJUVENATION; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; ORGANOGENESIS; PHYSIOLOGY; PROCEDURES; TISSUE REGENERATION; WOUND HEALING;

EXOSOMES; GUIDED TISSUE REGENERATION; HUMANS; ORGANOGENESIS; REGENERATIVE MEDICINE; REJUVENATION; STEM CELL TRANSPLANTATION; WOUND HEALING;

EID: 84958036885     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2016.1131976     Document Type: Review

References (127)

1. Basu J, Ludlow JW. Cell-based therapeutic products: potency assay development and application. Regen Med. 2014;9:497-512.
2. Guthrie K, Bruce A, Sangha N, et al. Potency evaluation of tissue engineered and regenerative medicine products. Trends Biotechnol. 2013;31:505-514.
3. Maguire G. Stem cell therapy without the cells. Commun Integr Biol. 2013;6:e26631. DOI:10. 4161/cib. 26631.
4. Justewicz DM, Shokes JE, Reavis B, et al. Characterization of the human smooth muscle cell secretome for regenerative medicine. Tissue Eng Part C Methods. 2012;18:797-816.
5. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11-15.
6. Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J Biol Chem. 1946;166:189-197.
7. Wolf P. The nature and significance of platelet products in human plasma. Br J Hematol. 1967;13:269-288. DOI:10. 1111/j. 1365-2141. 1967. tb08741. x.
8. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen presenting vesicles. J Exp Med. 1996;183:1161-1172.
9. Gould SJ, Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles. 2013;2:10. 3402.
10. Taylor DD, Homesley HD, Doellgast GJ. Binding of specific peroxidase-labeled antibody to placental type phosphatase on tumor-derived membrane fragments. Cancer Res. 1980;40:4064-4069.
11. Johnstone RM, Adam M, Hammond JR, et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412-9420.
12. Thery C, Clayton A, Amigorena S, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Prot Cell Biol. 2006;3. 22. 1-3. 22. 29. DOI:10. 1002/0471143030. cb0322s30.
13. Valadi H, Ekstrom K, Bossios A, et al. Exosome mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol. 2007;9:654-659.
14. Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell derived micro-vesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20:847-856.
15. Buck AH, Coakley G, Simbari F, et al. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014;5:5488.
16. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med. 1998;4:594-600.
17. http://exocarta. org/exosome-markers [cited 2015 Apr 11].
18. http://microvesicles. org/index. html [cited 2015 Apr 11].
19. Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4. DOI:10. 3402/jev. v4. 27066.
20. Adzick NS, Lorenz HP. Cells, matrix, growth factors and the surgeon. The biology of scarless fetal wound repair. Ann Surg. 1994;200:10-18. DOI:10. 1097/00000658-199407000-00003.
21. Roy S, Gatien S. Regeneration in axolotls: a model to aim for! Exp Gerontol. 2008;43:968-973.
22. Greco V, Hannus M, Eaton S. Argosomes: a potential vehicle for the spread of morphogens through epithelia. Cell. 2001;5:633-645. DOI:10. 1016/S0092-8674(01)00484-6.
23. Liegeouis S, Benedetto A, Garnier JM, et al. The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in Caenorhabditis elegans. J Cell Biol. 2006;173:949-961.
24. Tanaka Y, Okada Y, Hirokawa N. FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination. Nature. 2005;435:172-177.
25. Vyas N, Walvekar A, Tate D, et al. Vertebrate Hedgehog is secreted on two types of extracellular vesicles with different signaling properties. Sci Rep. 2014;4:7357. DOI:10. 1038/srep07357.
26. Danilchik M, Williams M, Brown E. Blastocoel spanning filopodia in cleavage stage Xenopus laevis: potential roles in morphogen distribution and detection. Dev Biol. 2013;382:70-81.
27. Buschow SI, van Balkom BW, Aalberts M, et al. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol. 2010;88:851-856.
28. Batagov AO, Kuznetsov VA, Kurochkin IV. Identification of nucleotide patterns enriched in secreted RNAs asputative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics. 2011;12(Suppl 3):S18. DOI:10. 1186/1471-2164-12-S3-S18.
29. Koppers-Lalic D, Hackenberg M, Bijnsdorp IV, et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 2014;8:1649-1658.
30. Irion U, St Johnston D. bicoid RNA localization requires specific binding of an endosomal sorting complex. Nature. 2007;445:554-558.
31. Gibbings DJ, Ciado C, Erhardt M, et al. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol. 2009;11:1143-1149.
32. Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007;110:2440-2448.
33. Rana S, Yue S, Stadel D, et al. Towards tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol. 2012;44:1574-1584.
34. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles and friends. J Cell Biol. 2013;200:373-383.
35. Aliotta JM, Pereira M, Li M, et al. Stable cell fate changes in marrow cells induced by lung-derived microvesicles. J Extracell Vesicles. 2012;10:3402.
36. Quesenberry PJ, Goldberg LR, Aliotta JM, et al. Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev. 2014;23:1429-1436.
37. Melo SA, Sugimoto H, O'Connell JT, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014;26: 707-721.
38. Zhang HG, Grizzle WE. Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. Am J Pathol. 2014;184:28-41.
39. Gupta A, Pulliam L. Exosomes as mediators of neuroinflammation. J Neuroinflammation. 2014;11:68.
40. Teixeira FG, Carvalho MM, Sousa N, et al. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration Cell Mol Life Sci. 2013;70:3871-3882.
41. Vishnubhatla I, Corteling R, Stevanato L, et al. The development of stem cell-derived exosomes as a cell-free regenerative medicine. J Circ Biomark. 2014;3:2. DOI:10. 5772/58597.
42. Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45:e54. DOI:10. 1038/emm. 2013. 94.
43. Liang X, Ding Y, Zhang Y, et al. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2013;9:1045-1059.
44. van Koppen A, Joles JA, van Balkom BW, et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS ONE. 2012;7:e38746. DOI:10. 1371/journal. pone. 0038746.
45. Ratajczak MZ, Kucia M, Jadczyk T, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies Leukemia. 2012;26:1166-1173.
46. Di Santo S, Yang Z, Wyler von Ballmoos M, et al. Novel cell free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One2009;e5643. DOI:10. 1371/ journal. pone. 0005643.
47. Doyle B, Sorajja P, Hynes B. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17:941-951.
48. Di Santo S, Yang Z, Wyler von Ballmoos M, et al. Endothelial progenitor cell derived conditioned medium promotes brain microvascular cell viability after ischemic insult in vitro. Cell Transplant. 2015;4:755.
49. Ionescu L, Byrne RN, van Haaften T, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol. 2012;303:L967-977.
50. Osugi M, Katagiri W, Yoshimi R, et al. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A. 2012;18:1479-1489.
51. Maumus M, Jorgensen C, Noël D. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie. 2013;95:2229-2234.
52. Toh WS, Foldager CB, Pei M, et al. Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration. Stem Cell Reviews and Reports. 2014;10:686-696.
53. Akyurekli C, Le Y, Richardson RB, et al. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev. 2015;11:150-160.
54. Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4:214-222.
55. Gatti S, Bruno S, Deregibus MC, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia reperfusion induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011;26:1474-1483.
56. Wang Y, Zhang L, Li Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61-69.
57. Kilpinen L, Impola U, Sankkila L, et al. Extracellular membrane vesicles from umbilical cord blood derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell Vesicles. 2013;10:3402.
58. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21: R125-34.
59. György B, Hung ME, Breakefield XO, et al. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Ann Rev Pharmacol Toxicol. 2015;55:439-464. DOI:10. 1146/annurev-pharmtox-010814-124630.
60. Lamichhane TN, Sokic S, Schardt JS, et al. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2015;21:45-54. DOI:10. 1089/ten. teb. 2014. 0300.
61. Sahoo S, Klychko E, Thorne T, et al. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ Res. 2011;109:724-728.
62. Lee C, Mitsialis SA, Aslam M, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia induced pulmonary hypertension. Circulation. 2012;126:2601-2611.
63. Zhang J, Guan J, Niu X, et al. Exosomes released from human induced pluripotent stem cells derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Trans Med. 2015;13:49. DOI:10. 1186/s12967-015-0417-0.
64. Ibrahim AG, Cheng K, Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2:606-619.
65. Kalani A, Tyagi A, Tyagi N. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2014;49:590-600.
66. Lai CP, Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Frontiers Physiol. 2012. DOI:10. 3389/fphys. 2012. 00228.
67. Krämer-Albers EM, Bretz N, Tenzer S, et al. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons Proteomics Clin Appl. 2007;1:1446-1461. DOI:10. 1002/prca. 200700522.
68. Bosse F. Extrinsic cellular and molecular mediators of peripheral axonal regeneration. Cell Tissue Res. 2012;349:5-14. DOI:10. 1007/s00441-012-1389-5.
69. Fruhbeis C, Frohlich D, Kuo WP, et al. 2013. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol e1001604. doi:10. 1371/journal. pbio. 1001604.
70. Takeda YS, Xu Q. Neuronal differentiation of human mesenchymal stem cells using exosomes derived from differentiating neuronal cells. PLoS One. 2015;e0135111. DOI:10. 1371/journal. pone. 0135111.
71. Lee HK, Finniss S, Cazacu S, et al. Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression. Stem Cells Dev. 2014;23:2851-2861.
72. Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18:1606-1614.
73. Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome-encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19:1769-1779. DOI:10. 1038/mt. 2011. 164.
74. Xin H, Li Y, Liu Z, et al. Systematic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33:1711-1715.
75. Zhang Y, Chopp M, Meng Y, et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 2015;122:856-867.
76. Doeppner TR, Herz J, Görgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4:1131-1143.
77. Xin H, Li Y, Liu Z, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31:2737-2746.
78. Bruce A, Ilagan R, Guthrie K, et al. Selected renal cells modulate disease progression in rodent models of chronic kidney disease via NFB and TGF1 pathways. Regen Med. 2015;10:815-839.
79. Fleury A, Martinez MC, Le Lay S. Extracellular vesicles as therapeutic tools in cardiovascular diseases. Front Immunol. 2014;5:370. DOI:10. 3389/fimmu. 2014. 00370.
80. Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014;15:4142-4157.
81. Harshyne LA, Hooper KM, Andrews EG, et al. Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol Immunother. 2015;64:299-309.
82. Vlassov AV, Magdaleno S, Setterquist R, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochimica et Biophysica Acta. 2012;1820:940-948.
83. Kordelas L, Rebmann V, Ludwig A-K, et al. 2013. MSCderived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28:970-973. DOI:10. 1038/leu. 2014. 41.
84. https://clinicaltrials. gov/ct2/show/NCT01294072term= exosome&rank=1 [cited 2015 Apr 11].
85. https://clinicaltrials. gov/ct2/show/NCT02565264term= exosome&rank=3 [cited 2015 Apr 11].
86. https://clinicaltrials. gov/ct2/show/NCT02138331term= exosome&rank=4 [cited 2015 Apr 11].
87. https://clinicaltrials. gov/ct2/show/NCT01668849term= exosome&rank=8 [cited 2015 Apr 11].
88. https://clinicaltrials. gov/ct2/show/NCT01159288term= exosome&rank=11 [cited 2015 Apr 11].
89. www. appliedbiologics. com [cited 2015 Apr 11].
90. Viaud S, Thery C, Ploix S, et al. Dendritic cell-derived exosomes for cancer immunotherapy: what's next Cancer Research. 2010;70:1281-1285.
91. Morse MA, Garst J, Osada T, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005;3:9. DOI:10. 1186/1479-5876-3-9.
92. Dai S, Wei D, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782-790.
93. Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med. 2005;3:10. DOI:10. 1186/1479-5876-3-10.
94. Zhang B, Wang M, Gong A, et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells. 2014. DOI:10. 1002/stem. 1771.
95. Lim CP, Phan TT, Lim IJ, et al. Stat3 contributes to keloid pathogenesis via promoting collagen production, cellproliferation, and migration. Oncogene. 2006;25: 5416-5425.
96. Madsen JT, Andersen KE. Microvesicle formulations used in topical drugs and cosmetics affect product efficiency, performance and allergenicity. Dermatitis. 2010;21: 243-247.
97. Liu JJ, Nazzal S, Chang TS, et al. Preparation and characterization of cosmeceutical liposomes loaded with avobenzone and arbutin. J Cosmet Sci. 2013;64:9-17.
98. Campani V, Marchese D, Pitaro MT, et al. Development of a liposome based formulation for vitamin K1 nebulization on the skin. Int J Nanomedicine. 2014;9:1823-1832.
99. Rahimpour Y, Hamishehkar H. Liposomes in cosmeceutics. Expert Opin Drug Deliv. 2012;9:443-455.
100. Seo KY, Kim DH, Lee SE, et al. Skin rejuvenation by microneedle fractional radiofrequency and a human stem cell conditioned medium in Asian skin: a randomized controlled investigator blinded split face study. J Cosmet Laser Ther. 2013;15:25-33.
101. Lee HJ, Lee EG, Kang S, et al. Efficacy of microneedling plus human stem cell conditioned medium for skin rejuvenation: a randomized, controlled, blinded split face study. Ann Dermatol. 2014;26:584-591.
102. Harn HJ, Huang MH, Huang CT, et al. Rejuvenation of aged pig facial skin by transplanting allogeneic granulocyte colony stimulating factor induced peripheral blood stem cells from a young pig. Cell Transplant. 2013;22: 755-765.
103. Kim WS, Park BS, Park SH, et al. Antiwrinkle effect of adipose-derived stem cell: activation of dermal fibroblast by secretory factors. J Dermatol Sci. 2009;53:96-102.
104. Shim JH, Park JY, Lee MG, et al. Human dermal stem/ progenitor cell-derived conditioned medium ameliorates ultraviolet a induced damage of normal human dermal fibroblasts. PLoS One 2013;e67604. DOI:10. 1371/journal. pone. 0067604.
105. Chen CC, Murray PJ, Jiang TX, et al. Regenerative hair waves in aging mice and extra-follicular modulators Follistatin, Dkk1 and Sfrp4. J Invest Dermatol. 2014;134:2086-2096.
106. Fukuoka H, Suga H. Hair regeneration treatment using adipose-derived stem cell conditioned medium: followup with trichograms. Eplasty. 2015;15:e10.
107. Ahmed MI, Alam M, Emelianov VU, et al. MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway. J Cell Biol. 2014;207:549-567.
108. Zhang GE, Grizzle WE. Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. Am J Pathol. 2014;184:28-41.
109. Harris DA, Patel SH, Gucek M, et al. Exosomes released from breast cancer carcinomas stimulate cell movement. PLoS One 2015;e0117495. DOI:10. 1371/journal. pone. 0117495.
110. Vallabhaneni KC, Penfornis P, Dhule S, et al. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins and metabolites. Oncotarget. 2015;6:4953-4967.
111. Li J, Sherman-Baust CA, Tsai-Turton M, et al. Claudin containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer. 2009;9:244. DOI:10. 1186/1471-2407-9-244.
112. Stenqvist AC, Nagaeva O, Baranov V, et al. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol. 2013;191:5515-5523.
113. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, et al. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol. 2002;14:713-722.
114. Théry C, Duban L, Segura E, et al. Indirect activation of naïve CD4+ T cells by dendritic cell derived exosomes. Nat Immunol. 2002;3:1156-1162.
115. Lai CP, Mardini O, Ericsson M, et al. Dynamic bio-distribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014;8:483-494.
116. Andre F, Escudier B, Angevin E, et al. Exosomes for cancer immunotherapy. Ann Oncol. 2004;15(Suppl 4):iv14, 1-4.
117. Chen TS, Arslan F, Yin Y, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESCderived MSCs. J Trans Med. 2011;9:47. DOI:10. 1186/ 1479-5876-9-47.
118. Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nature Commun. 2011;2:282. DOI:10. 1038/ncomms1285.
119. www. systembio. com [cited 2015 Apr 11].
120. Basu J, Ludlow JW. MSC sourced exosomes as therapeutic agents for wound healing and skin regeneration: from scaled production to functional regenerative outcomes in vitro and in vivo. International Society for Stem Cell Research Annual Meeting; 2015 Jun 24-27; Stockholm.
121. Basu J, Ludlow JW. Developmental engineering the kidney: leveraging principles of morphogenesis for renal regeneration. Birth Defects Res C Embryo Today. 2012;96:30-38.
122. Genheimer CW, Ilagan RM, Spencer T, et al. Molecular characterization of the regenerative response induced by intrarenal transplantation of selected renal cells in a rodent model of chronic kidney disease. Cells Tissues Organs. 2012;196:374-384.
123. www. fda. gov/BiologicsBloodVaccines/default. htm [cited2015 Apr 11].
124. Marcus ME, Leonard JN. FedExosomes: engineering therapeutic biological nanoparticles that truly deliver. Pharmaceuticals. 2013;6:659-680.
125. Kooijmans SA, Vader P, van Dommelen SM, et al. Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine. 2012;7:1525-1541.
126. Jeong D, Jo W, Yoon J, et al. Nanovesicles engineered from ES cells for enhanced cell proliferation. Biomaterials. 2014;35:9302-9310.
127. Ranghino A, Dimuccio V, Papadimitriou E, et al. Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration. Clin Kidney J. 2015;8:23-30.